No products in the cart.
MODULE 20: ETHICS, PROFESSIONALISM, AND COMPLIANCE
Section 20.5: Advocacy and Leadership for Pharmacist Provider Status
An examination of the pharmacist’s ethical duty to advance the profession, focusing on the key arguments for provider status and how to articulate the value of clinical pharmacy services to legislators, administrators, and the public.
SECTION 20.5
Advocacy and Leadership for Pharmacist Provider Status
From Untapped Potential to Unleashed Value: The Ethical Imperative to Advocate.
20.5.1 The “Why”: Advocacy as an Ethical Mandate
For too long, the quest for “provider status” has been framed as a purely professional goal—a matter of title, recognition, and reimbursement. It has been discussed in terms of what it means for us, the pharmacists. This perspective, while understandable, is fundamentally incomplete and ultimately unpersuasive. To truly grasp the urgency of this issue, we must reframe it entirely. The fight for provider status is not primarily about the advancement of our profession; it is an ethical imperative, deeply rooted in our core duties to our patients and to society.
The current system, which largely fails to recognize and reimburse pharmacists for their cognitive clinical services, is a systemic barrier to care. It creates an environment where your most valuable contributions—your ability to optimize complex medication regimens, manage chronic diseases, and prevent costly adverse events—are either provided for free, creating an unsustainable practice model, or worse, are not provided at all. This is not just a professional inconvenience; it is a profound ethical failure. It is a violation of the principles of beneficence and justice on a massive scale. We have an army of highly trained, accessible medication experts, and the system prevents them from being fully deployed in the fight against chronic disease.
The “Why” of this section is to transform you from a passive supporter of provider status into an active, articulate, and effective advocate. This requires a profound shift in mindset. You must see advocacy not as an extracurricular activity, but as a core professional competency and an ethical responsibility. We will deconstruct the complex legislative and regulatory landscape that governs this issue. We will arm you with the evidence-based arguments that prove the value of your services in the three languages that matter most to policymakers: improved quality, improved access, and reduced cost. You will learn to tailor your message to different stakeholders, from a state legislator to your own hospital’s CEO. This is not a course on lobbying; it is a masterclass in leadership. It is about empowering you to break down the barriers that prevent you from practicing at the top of your license, not for your own sake, but for the sake of the millions of patients who desperately need the care that only you can provide.
Pharmacist Analogy: The Over-Qualified Fire Inspector
Imagine a city where firefighters are among the most highly trained professionals. They spend nearly a decade learning not just how to extinguish fires, but advanced fire science: the chemistry of accelerants, the physics of structural collapse, and the engineering of fire suppression systems. They are, in effect, doctors of fire science.
However, due to an old city ordinance, these highly trained firefighters are only recognized and paid for one job: inspecting fire extinguishers. They spend their days going from building to building, checking tags and pressure gauges. During these inspections, they see catastrophic fire hazards everywhere—faulty wiring, blocked exits, disabled sprinkler systems. They have the knowledge to fix these problems and prevent a disaster, but the law doesn’t recognize them as “fire prevention providers.” They can point out the faulty wiring (identify a drug interaction), but they can’t be paid to fix it (manage the patient’s therapy). They can plead with the building owner (the patient) to clear the exits, but they have no authority or mechanism to implement a formal safety plan.
So they watch, frustrated, as buildings inevitably catch fire. When the alarm finally rings, they are allowed to rush to the scene and help the “real” fire department, but often only in a supporting role. They see the tragedies that could have been easily prevented if they had been allowed to use their full expertise earlier.
Advocating for provider status is the fight to change this archaic ordinance. It is the firefighters marching to city hall, not to demand better pay for inspecting extinguishers, but to demand the right to be recognized and deployed as the fire prevention experts they were trained to be. Their argument is not, “We deserve more.” Their argument is, “Let us save this city from burning down. Let us use our skills to prevent the fires, not just inspect the extinguishers.” This is your argument. You are not asking for a new title; you are demanding the right to prevent the catastrophic “fires” of chronic disease that you are uniquely qualified to stop.
20.5.2 Deconstructing the Barrier: What “Provider Status” Actually Means
To effectively advocate for change, you must first understand the precise nature of the problem. “Provider status” is a shorthand term for a complex set of legislative and regulatory issues. The central barrier at the federal level lies within the Social Security Act, the foundational law that created and governs the Medicare program. This law contains a specific list of professionals who are recognized as “providers” and are therefore eligible to bill Medicare Part B for their clinical services. Pharmacists are conspicuously absent from this list.
The Federal Hurdle: The Social Security Act
The inability to bill for services under Medicare Part B is the single greatest impediment to the widespread integration of pharmacists into collaborative care models, as many private payers base their own provider lists and reimbursement policies on Medicare’s standards. Achieving “provider status” at the federal level means amending the Social Security Act to add pharmacists to the list of recognized providers.
| Who IS a “Provider” Under Medicare Part B? | Who ISN’T a “Provider” Under Medicare Part B? |
|---|---|
|
Pharmacists are only recognized as suppliers of a product (Durable Medical Equipment under Part B or prescription drugs under Part D). The law does not recognize them as providers of clinical services. |
Current Workarounds and Their Limitations
In the absence of full provider status, health systems have developed several “workaround” billing mechanisms to receive some payment for pharmacist-led services. It is crucial to understand these, as they demonstrate the value of your services but also highlight the need for a more direct and sustainable model.
- “Incident-to” Billing: This is the most common method. A pharmacist’s services can be billed under a physician’s provider number as if the physician had performed them. Limitations: This requires direct physician supervision within the same office suite, is reimbursed at a lower rate, and legally attributes the work to the physician, making it impossible to track the pharmacist’s specific impact on quality metrics. It perpetuates the idea of the pharmacist as a physician-extender rather than an independent provider.
- Facility Fee Billing: In a hospital-based outpatient clinic, the hospital can charge a “facility fee” for the use of its clinical space and staff, which can include the pharmacist. Limitations: This does not reimburse for the professional service itself, only the overhead. It is not available in non-hospital-owned clinics.
- Chronic Care Management (CCM) Codes: Pharmacists can perform some of the clinical work under CCM codes, but the billing must still be submitted by an eligible provider (physician, NP, PA). Limitations: Same as “incident-to”—it fails to directly recognize the pharmacist’s contribution.
The State-Level Patchwork
While the federal battle continues, significant progress has been made at the state level. Many states have passed laws that either grant pharmacists provider status or mandate that state-regulated health plans (including Medicaid and state employee health plans) reimburse pharmacists for clinical services. This has created a complex patchwork of authorities across the country.
“Scope of Practice” is Not the Same as “Provider Status”
This is a critical distinction that is often confused. Your state’s Pharmacy Practice Act defines your scope of practice—the range of activities you are legally allowed to perform (e.g., administer immunizations, enter into collaborative practice agreements, order lab tests). Provider status and reimbursement laws determine whether you can get paid for performing those services. Many states have a broad, progressive scope of practice but no mechanism for reimbursement, leaving pharmacists as the only major healthcare professionals expected to provide clinical services for free.
20.5.3 Building the Bulletproof Case: The Three Pillars of Value
To successfully advocate for provider status, you must be fluent in the language of healthcare policy. This language is built on a framework known as the “Triple Aim,” now often expanded to the “Quadruple Aim.” Your arguments must be structured to demonstrate, with hard evidence, how recognizing pharmacists as providers directly advances these goals.
The Quadruple Aim: A Framework for Value
Improved Population Health
Better health outcomes for a defined group of patients.
Enhanced Patient Experience
Higher quality of care, better access, and greater satisfaction.
Reduced Per Capita Cost
Lowering the total cost of care for the health system.
Improved Provider Well-Being
Reducing burnout and improving the work life of the healthcare team.
Your advocacy must be a masterclass in translating your clinical activities into these four domains. We will structure the evidence around three key pillars: The Quality Argument, The Access Argument, and The Cost Argument.
The Quality Argument: Pharmacists Improve Health Outcomes
This is the clinical heart of your case. You must be armed with the data that proves that when pharmacists are integrated into care teams to manage medications, patients get better. Your argument should be built on landmark studies and focused on metrics that matter to payers and health systems.
Masterclass Table: Key Evidence for Pharmacist-Led Disease State Management
| Disease State | Landmark Study / Evidence Type | Key Finding: The Pharmacist’s Impact | How to Articulate This to a Policymaker |
|---|---|---|---|
| Diabetes | The Asheville Project (1997-2001) and numerous subsequent randomized controlled trials. | Patients receiving ongoing medication management and education from pharmacists saw a significant reduction in their A1c levels (average drop of 1-2%), improved adherence, and fewer long-term complications compared to usual care. | “In study after study, when a pharmacist is part of the diabetes care team, patients achieve better blood sugar control. This isn’t just a number; better control means we are preventing the downstream costs of blindness, amputations, and kidney failure that are bankrupting our healthcare system.” |
| Hypertension | Barber et al. (Lancet 2015) and the SPHÈRE-BP trial. | Pharmacist-led interventions, including patient education, adherence monitoring, and medication adjustments under a collaborative practice agreement, resulted in a significantly greater reduction in systolic blood pressure and a higher percentage of patients achieving their blood pressure goals compared to physician-only care. | “Hypertension is the number one driver of strokes and heart attacks. We have proven that when pharmacists are empowered to manage blood pressure medications, patients get to their goal faster and stay there. This is a low-cost, high-impact strategy to prevent the most expensive and devastating cardiovascular events.” |
| Hyperlipidemia | Systematic reviews and meta-analyses (e.g., Santschi et al., 2011). | Pharmacist involvement leads to significant reductions in LDL cholesterol and improved statin adherence. Pharmacists are particularly effective at overcoming “statin hesitancy” and managing side effects. | “Millions of Americans who should be on life-saving statins are not, often due to misinformation or manageable side effects. Pharmacists are trusted experts who can provide the intensive counseling needed to get these patients on the right therapy and keep them on it, preventing future heart attacks.” |
| Hospital Readmissions | Numerous studies on transitions of care. | Comprehensive pharmacist-led transitions of care programs—involving inpatient counseling, discharge medication reconciliation, and post-discharge follow-up calls—have been shown to reduce 30-day hospital readmission rates by up to 50%. | “Hospitals in our state are penalized millions of dollars every year when patients are readmitted. The evidence is overwhelming that the single most effective way to prevent these readmissions is to have a pharmacist manage the patient’s medications during their transition home. Reimbursing for this service isn’t a cost; it’s an investment with a proven return.” |
The Access Argument: Pharmacists are in the Community
This is your argument against the geographic and capacity limitations of the current healthcare system. You must position pharmacists not as competitors to physicians, but as essential partners in extending the reach of primary care.
The Core Message: Physicians are a scarce and concentrated resource. Pharmacists are a widely distributed and underutilized resource. Recognizing pharmacists as providers unlocks a massive new workforce to help manage the overwhelming burden of chronic disease, especially in areas that need it most.
Key Statistics for Your Advocacy Toolkit
- Approximately 90% of Americans live within 5 miles of a community pharmacy.
- Patients see their community pharmacist an average of 10 times more frequently than they see their primary care physician.
- There are over 88,000 pharmacies in the United States, providing a massive existing infrastructure for care delivery.
- Pharmacists can fill the care gap in designated Health Professional Shortage Areas (HPSAs), particularly in rural and underserved urban communities where physician access is severely limited.
The Cost Argument: Paying Pharmacists Saves the System Money
This is the argument that ultimately gets legislation passed and convinces administrators to invest. You must demonstrate that pharmacist services are not a new cost, but a reallocation of resources that produces a significant return on investment (ROI) by preventing more expensive downstream events.
The Core Message: Non-optimized medication therapy is not free. It costs the U.S. healthcare system over $528 billion per year in morbidity and mortality, primarily from medication non-adherence and untreated disease. Paying a pharmacist a relatively small amount to manage medications prevents the hugely expensive hospitalizations and emergency room visits that make up the bulk of this cost.
Masterclass Table: The Economics of Pharmacist Care
| Pharmacist Intervention | Demonstrated Cost Savings Mechanism | Return on Investment (ROI) Estimate | How to Articulate This to a CFO |
|---|---|---|---|
| Comprehensive Medication Management (CMM) in Diabetes | Reduced A1c levels lead to fewer costly long-term complications (nephropathy, retinopathy, amputations). Improved adherence prevents unnecessary ER visits for hyperglycemia. | Studies consistently show an ROI of $3 to $12 saved for every $1 spent on pharmacist-led CMM services. | “For every dollar we invest in salary for a clinical pharmacist to manage our highest-risk diabetes patients, we can expect to save between three and twelve dollars in reduced hospital and specialty care costs. This isn’t just good care; it’s a sound financial strategy.” |
| Transitions of Care / Discharge Counseling | Prevents medication errors and non-adherence post-discharge, which are the leading causes of preventable 30-day hospital readmissions. | Each prevented readmission saves an average of $15,000-$20,000. A single pharmacist can prevent dozens of readmissions per year, generating a massive positive ROI while also avoiding Medicare penalties. | “Our current readmission penalty is costing us over a million dollars a year. By embedding pharmacists in our discharge process, we can directly reduce that penalty. The business case is straightforward: the pharmacist’s salary will be more than covered by the reduction in penalties alone, not to mention the actual cost savings from the averted admissions.” |
| Pharmacist-Led Immunization Programs | Increases vaccination rates for influenza, pneumonia, and shingles, preventing costly hospitalizations for these illnesses. | Each influenza hospitalization prevented saves ~$4,500. Each shingles hospitalization prevented saves ~$20,000. | “Expanding our pharmacist’s scope to include a full range of adult immunizations under a collaborative practice agreement is one of the highest-yield preventative health investments we can make. It leverages our existing infrastructure to reduce the seasonal strain on our inpatient services.” |
20.5.4 From Evidence to Influence: Tailoring Your Message
Having the evidence is only half the battle. To be an effective advocate, you must be a masterful communicator, capable of tailoring your message to resonate with the specific priorities and concerns of your audience. A legislator cares about different metrics than a hospital administrator, who cares about different things than a patient. You must learn to speak their language.
Audience 1: Legislators and Policymakers
Their Primary Concerns: Constituent health, state/federal budgets, economic impact, and re-election. They think in terms of large-scale problems and solutions that affect their entire district or state.
Your Strategy: Frame your argument in terms of broad public good.
Key Talking Points:
- Solving the Access Crisis: “In the rural parts of your district, my colleagues and I are often the only healthcare professionals for 50 miles. We are a ready-made solution to the primary care shortage.”
- Fiscal Responsibility: “This isn’t about spending more money; it’s about spending our current healthcare dollars more wisely. By paying pharmacists to prevent diseases from getting worse, we save the state’s Medicaid budget millions in avoidable hospital bills.”
- The Personal Story: “Let me tell you about a constituent of yours, a farmer with diabetes, whose life was saved because a local pharmacist was able to work with his doctor to get his insulin regimen right…” (Stories are more powerful than statistics).
Audience 2: Hospital and Clinic Administrators
Their Primary Concerns: Financial bottom line, operational efficiency, quality metrics (Star Ratings, HEDIS), patient satisfaction scores (HCAHPS), and reducing penalties.
Your Strategy: Frame your argument as a business case.
Key Talking Points:
- Return on Investment (ROI): “I’ve developed a pro forma that shows by investing in a new pharmacist-led transitions of care service, we can project a 4:1 ROI within two years based on conservative estimates of readmission reduction.”
- Quality Improvement: “Our health plan’s Star Rating for medication adherence is currently at 3 stars. The data shows that pharmacist-led MTM can raise that to 4 or 5 stars, which translates directly into millions of dollars in quality bonus payments from Medicare.”
- Provider Burnout: “Our primary care physicians are overwhelmed with medication management. By hiring a clinical pharmacist to handle this, we can offload their work, increase their efficiency, improve their job satisfaction, and allow them to see more patients.”
Audience 3: The Public and Patients
Their Primary Concerns: Their own health, convenience, out-of-pocket costs, and having a trusting relationship with their provider.
Your Strategy: Frame your argument in terms of personal benefit.
Key Talking Points:
- More Convenient Care: “Instead of having to wait three weeks to see your doctor for a simple blood pressure check, imagine being able to walk into your local pharmacy and have a pharmacist who works with your doctor make the adjustment you need right away.”
- A Medication Expert on Your Team: “Your doctor is the expert on diagnosing your condition. Your pharmacist is the expert on the medications used to treat it. By allowing us to work together as recognized providers, you get a more complete team focused on your health.”
- Saving You Money: “When a pharmacist helps you manage your medications properly, you are less likely to end up in the emergency room or the hospital, which can save you thousands of dollars in co-pays and deductibles.”
